levofloxacin has been researched along with Abscess, Abdominal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruns, T; Büning, J; Fichtner-Feigl, S; Kruis, W; Maaser, C; Preiß, JC; Reuken, PA; Schmelz, R; Stallmach, A; Teich, N | 1 |
| Chuah, SK; Gollapudi, S; Thadepalli, H | 1 |
2 other study(ies) available for levofloxacin and Abscess, Abdominal
| Article | Year |
|---|---|
Microbial Spectrum of Intra-Abdominal Abscesses in Perforating Crohn's Disease: Results from a Prospective German Registry.
Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; beta-Lactamase Inhibitors; Candida albicans; Carbapenems; Cephalosporins; Crohn Disease; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterococcus; Female; Germany; Humans; Immunosuppressive Agents; Intestinal Perforation; Length of Stay; Levofloxacin; Male; Penicillins; Prospective Studies; Quinolones; Registries; Streptococcus; Young Adult | 2018 |
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fluoroquinolones; Injections, Subcutaneous; Levofloxacin; Male; Metronidazole; Mice; Moxifloxacin; Ofloxacin; Quinolines | 2004 |